The Real-Life Efficacy and Safety of Telmisartan in Patients With Arterial Hypertension (METABOLIC)

Bayer

Status: Completed

Conditions: Hypertension

Treatments: Drug: Pritor (Telmisartan , BAY68-9291)

Study type: Observational

Funder types: Industry

Identifiers

NCT00471003

13929 - KL0601SI

14326 - KL0601HR

KL0601PL

12804 - KL0601SK

12729

Details and patient eligibility

About

The main purpose of this study is to asses the efficacy and safety of telmisartan, with the special attention on the influence of telmisartan on selected metabolic parameters of patients.

Enrollment: 5,448 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Age over 18
• Untreated or ineffectively treated arterial hypertension

Exclusion criteria

• Cholestatic disorders and severe hepatic failure
• Allergy to telmisartan
• Pregnancy and lactation period

Trial design

5,448 participants in 1 patient group

Arm 1

Treatment:

Drug: Pritor (Telmisartan , BAY68-9291)